![Mats Gunnar Pettersson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 168 113 $ au 31/05/2026
Fondateur de Swedish Orphan Biovitrum AB, Biovitrum AB et SwedenBIO Service AB, Mats Gunnar Pettersson est un entrepreneur et un homme d'affaires suédois qui a été à la tête de 7 entreprises différentes. Il siège au conseil d'administration de Magle AB, Malthouse Invest AB, Magle Chemoswed AB et Magle Chemoswed Holding AB. Il a précédemment occupé les postes de président de Genmab A, président d'Independent Pharmaceutica AB, président de Moberg Pharma AB, président de NsGene A, directeur général de Swedish Orphan Biovitrum AB et directeur général de Biovitrum AB (une filiale de Swedish Orphan Biovitrum AB), président de H. Lundbeck A, premier vice-président de Pharmacia Corp. et vice-président de SwedenBIO Service AB. Mats Gunnar Pettersson a obtenu un diplôme d'études supérieures du Handelshgskolan i Gteborg.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/03/2025 | 443 500 ( 1,47% ) | 168 113 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MAGLE CHEMOSWED HOLDING AB | Directeur/Membre du Conseil | 01/01/2016 |
Malthouse Invest AB | Directeur/Membre du Conseil | - |
Magle Chemoswed AB
 Magle Chemoswed AB Medical SpecialtiesHealth Technology Designs and develops microspheres medical devices | Directeur/Membre du Conseil | 01/04/2016 |
Magle AB
 Magle AB Chemicals: Major DiversifiedProcess Industries Manufactures chemical products | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| GENMAB A/S | Président | 26/03/2020 |
| MOBERG PHARMA AB | Président | 18/05/2016 |
| PHOTOCURE ASA | Directeur/Membre du Conseil | 01/01/2015 |
| H. LUNDBECK A/S | Président | 21/03/2013 |
| ABLYNX | Directeur/Membre du Conseil | 01/02/2013 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 23 |
|---|---|
Biacore International AB
 Biacore International AB Pharmaceuticals: MajorHealth Technology Offers systems that generate data on the interactions between proteins and small molecule drug candidates | Health Technology |
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Genmab A/S
 Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
Photocure ASA
 Photocure ASA Medical SpecialtiesHealth Technology Develops and sells pharmaceuticals and medical devices | Health Technology |
Active Biotech AB
 Active Biotech AB BiotechnologyHealth Technology Develops drugs for cancer, neurodegenerative and inflammatory diseases | Health Technology |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Commercial Services |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
NsGene A/S
 NsGene A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic products for the treatment of neurodegenerative disorders | Health Technology |
to-BBB Holding BV
 to-BBB Holding BV Pharmaceuticals: GenericHealth Technology Operates as a holding company with interests in providing central nervous system drug technology to the pharmaceutical and biotechnology industries | Health Technology |
to-BBB technologies BV
 to-BBB technologies BV Pharmaceuticals: MajorHealth Technology Develops medicines for brain disease treatment | Health Technology |
Aquapharm Biodiscovery Ltd.
 Aquapharm Biodiscovery Ltd. Pharmaceuticals: MajorHealth Technology Operates as a marine biotechnology company which develops antibiotics to treat drug-resistant infections | Health Technology |
Moberg Pharma AB
 Moberg Pharma AB Pharmaceuticals: MajorHealth Technology Develops and commercializes medical products | Health Technology |
Independent Pharmaceutica AB
 Independent Pharmaceutica AB Medical DistributorsDistribution Services Provides pharmacological solutions for treatment of nicotine addiction. | Distribution Services |
Handelshögskolan i Göteborg
 Handelshögskolan i Göteborg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services Provides educational services | Commercial Services |
Biacore AB | |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Metacure Ltd. | |
Magle AB
Magle AB Chemicals: Major DiversifiedProcess Industries Manufactures chemical products | Process Industries |
Malthouse Invest AB | |
Magle Chemoswed AB
Magle Chemoswed AB Medical SpecialtiesHealth Technology Designs and develops microspheres medical devices | Health Technology |
Magle Chemoswed Holding AB
 Magle Chemoswed Holding AB BiotechnologyHealth Technology Engages in contract development and manufacturing of medicines and medical devices | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
